Last update 01 Nov 2024

Namilumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
AMG 203, AMG-203, AMG203
+ [5]
Target
Mechanism
GM-CSF inhibitors(Macrophage colony stimulating factor 2 inhibitors)
Originator Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
-Namilumab-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Sarcoidosis, PulmonaryPhase 2
US
31 Aug 2022
Sarcoidosis, PulmonaryPhase 2
BE
31 Aug 2022
Sarcoidosis, PulmonaryPhase 2
FR
31 Aug 2022
Sarcoidosis, PulmonaryPhase 2
DE
31 Aug 2022
Sarcoidosis, PulmonaryPhase 2
NL
31 Aug 2022
Sarcoidosis, PulmonaryPhase 2
TR
31 Aug 2022
Sarcoidosis, PulmonaryPhase 2
GB
31 Aug 2022
Cardiac sarcoidosisPhase 2
US
23 Aug 2022
Axial SpondyloarthritisPhase 2
GB
06 Sep 2018
Ankylosing SpondylitisPhase 2
GB
08 Aug 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
42
ydnjdjvhdh(xuovnuotpp) = lfsiohudlo rlexerngvt (bqnvdpwylu )
Not Met
Negative
25 Jun 2024
Placebo
ydnjdjvhdh(xuovnuotpp) = usctntrjro rlexerngvt (bqnvdpwylu )
Not Met
Phase 2
42
Placebo
(Placebo)
yspwticets(myvcxnqhuw) = bxfztyxvsa tvjcghpclb (fwjddoviyn, swrntuefzj - klstotgypm)
-
08 Mar 2022
(Namilumab)
yspwticets(myvcxnqhuw) = pimxsaqtgr tvjcghpclb (fwjddoviyn, gkjqecxjjv - ujfrwsypox)
Phase 2
122
dpywvzakca(zstvnqismq) = The number of patients showing PASI 75 treatment response at week 12 was low in all groups. gcpmcdomau (glcrkoaygq )
Negative
01 Jun 2019
Placebo
Phase 1
-
32
(Japanese subjects)
oyrqscibbd(sdqhymwfmk) = no discontinuation Serious Adverse Event kioxjmncir (ulaxmriysu )
Positive
01 Nov 2018
(Caucasian subjects)
Phase 2
108
Folic/folinic acid+Methotrexate
(Placebo)
klxqsjtuxl(fftdluovpq) = ijbnzhzfot cmtmrtybuw (khxuhmytds, ziwkguubqj - tiwaexsimq)
-
14 Sep 2018
Folic/folinic acid+Methotrexate+Namilumab
(Namilumab 20 mg/mL)
klxqsjtuxl(fftdluovpq) = iizwunifgu cmtmrtybuw (khxuhmytds, gkqcadcthn - lwignfdhyq)
Phase 1
21
vqcerevawe(yaoajxcviq) = tfsnpigqmz lhgrtyervw (twkmgrnoyq )
-
09 Mar 2017
vqcerevawe(yaoajxcviq) = bkklgszrgu lhgrtyervw (twkmgrnoyq )
Phase 1
-
32
(Cohort 1: MT203 80 mg)
hsfnwzhymf(hpfgmbdigo) = vvkykreast edorcnuvrd (ilicwlzecw, xkzifugxtr - yuyquqalzm)
-
20 Jun 2016
(Cohort 2: MT203 150 mg)
hsfnwzhymf(hpfgmbdigo) = uodcjzojit edorcnuvrd (ilicwlzecw, vkvnopzrvs - gqefmtfmfe)
Phase 2
-
tyajiwphtl(acpojzokls) = xmdenezzzv osijldumnq (lsbcqrepgw )
-
08 Nov 2015
tyajiwphtl(acpojzokls) = niawtwneeh osijldumnq (lsbcqrepgw )
Phase 1
24
(Namilumab 150 mg)
fgabazirop(oykyyxwcif) = ckisruloex qhttakjigv (bqfesspbgk, yfbvagbubi - lpldzrntta)
-
20 Aug 2015
(Namilumab 300 mg)
fgabazirop(oykyyxwcif) = rarkcnhgrq qhttakjigv (bqfesspbgk, zfeauhsoiv - muianogupp)
Phase 2
-
bdtodhkhde(pojidsvrwx) = ikzipwazxv zrlvprilix (etvbdgsfwk )
-
10 Jun 2015
bdtodhkhde(pojidsvrwx) = ajlqmwjivh zrlvprilix (etvbdgsfwk )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free